Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $74.0 million.

  • GE HealthCare Technologies' Depreciation & Amortization (CF) rose 1384.62% to $74.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $287.0 million, marking a year-over-year increase of 708.96%. This contributed to the annual value of $287.0 million for FY2025, which is 708.96% up from last year.
  • GE HealthCare Technologies' Depreciation & Amortization (CF) amounted to $74.0 million in Q4 2025, which was up 1384.62% from $75.0 million recorded in Q3 2025.
  • Over the past 5 years, GE HealthCare Technologies' Depreciation & Amortization (CF) peaked at $75.0 million during Q3 2025, and registered a low of $56.0 million during Q1 2022.
  • Over the past 4 years, GE HealthCare Technologies' median Depreciation & Amortization (CF) value was $64.5 million (recorded in 2023), while the average stood at $64.4 million.
  • Data for GE HealthCare Technologies' Depreciation & Amortization (CF) shows a peak YoY increase of 1384.62% (in 2025) and a maximum YoY decrease of 294.12% (in 2025) over the last 5 years.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Depreciation & Amortization (CF) stood at $59.0 million in 2022, then increased by 1.69% to $60.0 million in 2023, then increased by 8.33% to $65.0 million in 2024, then rose by 13.85% to $74.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $74.0 million in Q4 2025, compared to $75.0 million in Q3 2025 and $72.0 million in Q2 2025.